Foundation Partners Fund

www.foundationventure.com

VCMatch tracks Foundation Partners Fund as an investor focused on Biotech, Medtech, and Digital Health companies, Pre-Seed and Seed rounds, New Jersey and United States markets, and $500k to $1m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$500k to $1m

Stages

Pre-Seed, Seed

Focus Areas

Biotech, Medtech, Digital Health

Geography

New Jersey and United States

Investment Thesis

Foundation Venture Capital Group (FVCG) practices impact investing focused on very early-stage, health-related technologies emerging from affiliated New Jersey research institutions. They combine pre-seed and seed capital with sustained, hands-on nonmonetary support — strategic, operational and back-office — beginning “prior to the incorporation of the start-up company and extend[ing] through the life cycle of the company to the time potential funding from traditional venture capital companies may be possible.” The firm invests with the dual goal of advancing commercialization that benefits patients and communities while generating “positive, measurable social impact” whose gains are reinvested into furthering research and innovation at their Affiliated Organizations.

Is Foundation Partners Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Foundation Partners Fund is most relevant for founders raising Pre-Seed and Seed rounds in Biotech, Medtech, Digital Health, and Pharma, especially across New Jersey and United States, with public check-size signals around $500k to $1m.

Focus statement

FVCG "uses impact investing to provide pre-seed and seed funding to health-related start-up companies at their partner organizations to help them advance toward and through commercialization." The geographic and institutional focus is New Jersey and organizations with formal affiliation agreements (university and health-system spinouts).

Value Add

Explicit impact-investing mandate: investments intended to "generate positive, measurable social impact" with financial gains reinvested into affiliated research and innovation.
Tight affiliation model: capital is prioritized for companies formed by researchers/clinicians at organizations with Affiliation Agreements (e.g., Rutgers, Princeton, Hackensack Meridian Health).
Capital + operational support: provides both funding and substantive nonmonetary assistance (strategic, operational, back-office) starting before incorporation and continuing until the company can attract traditional VC.
Integrated funding continuum: part of a family of entities (Foundation for Health Advancement, New Jersey Health Foundation) that provide grant, innovation-grant and VC seed funding to move technologies from early research through commercialization.
Patient- and commercialization-driven selection: emphasis on translational research that addresses unmet clinical needs and can reach patients (e.g., diagnostics, therapeutics, medical devices).
Evergreen / reinvestment orientation: proceeds are described as being reinvested into research and innovation at affiliated organizations, supporting a sustaining ecosystem.